Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

New treatments for seborrheic dermatitis show promise for difficult cases.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Fzd2 is important for skin and hair development through various signaling ways.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Alopecia areata causes unpredictable hair loss and requires personalized treatment.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Dupilumab may worsen hair loss in patients with alopecia areata.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Different γδ T cell types have unique roles in causing alopecia areata.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

Dupilumab may cause hair loss, so patients should be monitored.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.

The study suggests that hypothyroidism may cause alopecia areata.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.